替诺福韦二异丙基（TDF）对慢性乙型肝炎（CHB）患者与未治

StephenW

Effect of TenofovirDisoproxyl(TDF) on Hepatocellular Carcinoma (HCC) Incidence in Patients with Chronic Hepatitis B (CHB) Compared to Untreated Patients:A Multicenter Study with Propensity Score Matching (PSM)
	Reported by Jules Levim AASLD - Presented at AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC MindieH. Nguyen1, Hwai-I Yang2, An K. Le1, NghiaH. Nguyen3, Jian Q. Zhang4, Chris Wong5, Clifford Wong5, HuyTrinh61. Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, United States2. Genomics Research Center, Academia Sinica, Taiwan, Taipei, Taiwan3. Internal Medicine, University of California, San Diego, San Diego, CA, United States4. Chinese Hospital, San Francisco, CA, United States5. Wong Clinics, San Francisco, CA, United States6. San Jose Gastroenterology, San Jose, CA, United States This study was supported by an investigator-initiated grant to Stanford University by Gilead Sciences.